Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Di Carlo

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Il Farmaco; Edizione Scientifica|May 1, 1980
Effects of estrogens P-1496 and P-1560 on the binding of estradiol with rat uterine estrogen receptorsF Di Carlo, G Conti, C Reboani, et al.
Pharmacological Research|April 1, 1996
Evidence for functional beta-adrenoceptor subtypes in CG-5 breast cancer cellG R Badino, A Novelli, C Girardi, et al.
Pharmacological Research Communications|August 1, 1988
Effects of medroxyprogesterone acetate on serum prolactin levels and liver prolactin binding capacity in the ratG Muccioli, S Racca, S Ricci Gamalero, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1985
Effects of medroxyprogesterone acetate on DMBA-induced mammary tumorsS Racca, G Conti, A Crispino, et al.
Journal of Veterinary Pharmacology and Therapeutics|September 1, 1993
Regulation of uterine estrogen receptors (ER) by beta-adrenergic stimulation in immature ratsG Re, P Badino, M Dacasto, et al.
The International Journal of Biological Markers|January 1, 1986
A combined histological, immunocytochemical and biochemical approach in the evaluation of estrogen receptors in breast carcinomasF Pietribiasi, P Gugliotta, S Racca, et al.
The Italian Journal of Surgical Sciences|January 1, 1983
The correlation between estrogen receptor status, axillary-node metastases and disease-free interval after surgery in primary breast cancerL Caldarola, P Calderini, P Volterrani, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Potentiation of medroxyprogesterone acetate antineoplastic activity by histidine in rat mammary tumoursF Di Carlo, G Conti, M Giubertoni, et al.
Virchows Archiv : an International Journal of Pathology|February 17, 1998
Growth inhibition of DMBA-induced rat mammary carcinomas by UK 114S Racca, F Di Carlo, A Bartorelli, et al.
International Journal of Cancer|May 15, 1988
High tumour prolactin receptor content and lack of increase in serum prolactin levels as predictors of good response to endocrine therapy in rat mammary cancerF Di Carlo, G Muccioli, G Bellussi, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Il Farmaco; Edizione Scientifica|May 1, 1980
Effects of estrogens P-1496 and P-1560 on the binding of estradiol with rat uterine estrogen receptorsF Di Carlo, G Conti, C Reboani, et al.
Pharmacological Research|April 1, 1996
Evidence for functional beta-adrenoceptor subtypes in CG-5 breast cancer cellG R Badino, A Novelli, C Girardi, et al.
Pharmacological Research Communications|August 1, 1988
Effects of medroxyprogesterone acetate on serum prolactin levels and liver prolactin binding capacity in the ratG Muccioli, S Racca, S Ricci Gamalero, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1985
Effects of medroxyprogesterone acetate on DMBA-induced mammary tumorsS Racca, G Conti, A Crispino, et al.
Journal of Veterinary Pharmacology and Therapeutics|September 1, 1993
Regulation of uterine estrogen receptors (ER) by beta-adrenergic stimulation in immature ratsG Re, P Badino, M Dacasto, et al.
The International Journal of Biological Markers|January 1, 1986
A combined histological, immunocytochemical and biochemical approach in the evaluation of estrogen receptors in breast carcinomasF Pietribiasi, P Gugliotta, S Racca, et al.
The Italian Journal of Surgical Sciences|January 1, 1983
The correlation between estrogen receptor status, axillary-node metastases and disease-free interval after surgery in primary breast cancerL Caldarola, P Calderini, P Volterrani, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Potentiation of medroxyprogesterone acetate antineoplastic activity by histidine in rat mammary tumoursF Di Carlo, G Conti, M Giubertoni, et al.
Virchows Archiv : an International Journal of Pathology|February 17, 1998
Growth inhibition of DMBA-induced rat mammary carcinomas by UK 114S Racca, F Di Carlo, A Bartorelli, et al.
International Journal of Cancer|May 15, 1988
High tumour prolactin receptor content and lack of increase in serum prolactin levels as predictors of good response to endocrine therapy in rat mammary cancerF Di Carlo, G Muccioli, G Bellussi, et al.
Pageof 5